Tratamiento del virus de la hepatitis B: ¿qué pacientes deben recibir tratamiento inmediato?
Robert P. Perrillo – 13 January 2014 – Watch a video presentation of this article
Improving survival of cirrhosis patients with hepatocellular carcinoma through application of standard of care
Edoardo G. Giannini, Franco Trevisani – 13 January 2014
Virus de la hepatitis C: Terapia antiviral en pacientes en la lista de espera
Asmeen Bhatt, y Gregory T. Everson – 13 January 2014 – Watch a video presentation of this article
Virus de la hepatitis C: Terapia antiviral en pacientes en la lista de espera
Asmeen Bhatt, y Gregory T. Everson – 13 January 2014 – Watch a video presentation of this article
Insuficiencia renal y trasplante hepático
Thomas D. Boyer, y Bruce Kaplan – 13 January 2014 – Watch a video presentation of this article
Infección por el virus de la hepatitis C en pacientes con enfermedad renal crónica
Andres F. Carrion,, y Paul Martin, – 13 January 2014 – Watch a video presentation of this article
Tratamiento del virus de la hepatitis B: Cuáles pacientes deberían ser tratados con los análogos de nucleós(t)idos
Mauro Viganò, y Pietro Lampertico – 13 January 2014 – Watch a video presentation of this article
Cost‐effectiveness of sofosbuvir‐based triple therapy for untreated patients with genotype 1 chronic hepatitis C
Salvatore Petta, Giuseppe Cabibbo, Marco Enea, Fabio Salvatore Macaluso, Antonella Plaia, Raffaele Bruno, Antonio Gasbarrini, Antonio Craxì, Calogero Cammà, WEF Study Group – 13 January 2014 – We assessed the cost‐effectiveness of sofosbuvir (SOF)‐based triple therapy (TT) compared with boceprevir (BOC)‐ and telaprevir (TVR)‐based TT in untreated genotype 1 (G1) chronic hepatitis C (CHC) patients discriminated according to IL28B genotype, severity of liver fibrosis, and G1 subtype. The available published literature provided the data source.
Cost‐effectiveness of sofosbuvir‐based triple therapy for untreated patients with genotype 1 chronic hepatitis C
Salvatore Petta, Giuseppe Cabibbo, Marco Enea, Fabio Salvatore Macaluso, Antonella Plaia, Raffaele Bruno, Antonio Gasbarrini, Antonio Craxì, Calogero Cammà, WEF Study Group – 13 January 2014 – We assessed the cost‐effectiveness of sofosbuvir (SOF)‐based triple therapy (TT) compared with boceprevir (BOC)‐ and telaprevir (TVR)‐based TT in untreated genotype 1 (G1) chronic hepatitis C (CHC) patients discriminated according to IL28B genotype, severity of liver fibrosis, and G1 subtype. The available published literature provided the data source.
Single‐center experience and long‐term outcomes of duct‐to‐duct biliary reconstruction in infantile living donor liver transplantation
Hidekazu Yamamoto, Shintaro Hayashida, Katsuhiro Asonuma, Masaki Honda, Hiroko Suda, Takahiro Murokawa, Yuki Ohya, Kwang‐Jong Lee, Takayuki Takeichi, Yukihiro Inomata – 10 January 2014 – The indications for duct‐to‐duct (DD) biliary reconstruction in living donor liver transplantation (LDLT) for small children are still controversial. In this study, the feasibility of DD biliary reconstruction versus Roux‐en‐Y (RY) biliary reconstruction was investigated in terms of long‐term outcomes.